Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT02825420
Eligibility Criteria:
Inclusion Criteria:
* Women aged 18 years or older.
* Presence of platinum-sensitive relapsed ovarian cancer.
* Treatment and treated indication according to local label SmPC and reimbursement for trabectedin and PLD treatment.
* Prior treatment with a minimum of 1 cycle of trabectedin + PLD according to SmPC before inclusion in the study, and no more than 3 previous treatment lines.
* Written informed consent indicating that patients understand the purpose and procedures and are willing to participate in the study.
Exclusion Criteria:
* None
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02825420
Study Brief:
Protocol Section:
NCT02825420